Your browser doesn't support javascript.
loading
Acquired resistance to endocrine treatments is associated with tumor-specific molecular changes in patient-derived luminal breast cancer xenografts.
Cottu, Paul; Bièche, Ivan; Assayag, Franck; El Botty, Rania; Chateau-Joubert, Sophie; Thuleau, Aurélie; Bagarre, Thomas; Albaud, Benoit; Rapinat, Audrey; Gentien, David; de la Grange, Pierre; Sibut, Vonick; Vacher, Sophie; Hatem, Rana; Servely, Jean-Luc; Fontaine, Jean-Jacques; Decaudin, Didier; Pierga, Jean-Yves; Roman-Roman, Sergio; Marangoni, Elisabetta.
Afiliação
  • Cottu P; Departments of Medical Oncology and Laboratory of Preclinical Investigation, Translational Research Department;
  • Bièche I; Genetics, Hospital, Institut Curie;
  • Assayag F; Laboratory of Preclinical Investigation, Translational Research Department;
  • El Botty R; Laboratory of Preclinical Investigation, Translational Research Department;
  • Chateau-Joubert S; Pathology Department, National Veterinary School of Alfort, Maisons Alfort, France.
  • Thuleau A; Laboratory of Preclinical Investigation, Translational Research Department;
  • Bagarre T; Laboratory of Preclinical Investigation, Translational Research Department;
  • Albaud B; Affymetrix Platform, Translational Research Department;
  • Rapinat A; Affymetrix Platform, Translational Research Department;
  • Gentien D; Affymetrix Platform, Translational Research Department;
  • de la Grange P; Genosplice;
  • Sibut V; Bioinformatics Unit, Inserm U900 Mines ParisTech;
  • Vacher S; Genetics, Hospital, Institut Curie;
  • Hatem R; Genetics, Hospital, Institut Curie;
  • Servely JL; INRA, Phase Department; Pathology Department, National Veterinary School of Alfort, Maisons Alfort, France.
  • Fontaine JJ; Pathology Department, National Veterinary School of Alfort, Maisons Alfort, France.
  • Decaudin D; Departments of Medical Oncology and Laboratory of Preclinical Investigation, Translational Research Department;
  • Pierga JY; Departments of Medical Oncology and.
  • Roman-Roman S; Translational Research Department, Institut Curie, Paris, France; and.
  • Marangoni E; Laboratory of Preclinical Investigation, Translational Research Department; elisabetta.marangoni@curie.fr.
Clin Cancer Res ; 20(16): 4314-25, 2014 Aug 15.
Article em En | MEDLINE | ID: mdl-24947930

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Regulação Neoplásica da Expressão Gênica / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Hormonais / Receptor alfa de Estrogênio Tipo de estudo: Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Regulação Neoplásica da Expressão Gênica / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Hormonais / Receptor alfa de Estrogênio Tipo de estudo: Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article